Health knowledge made personal
WellPage for Sarcoma
+ Bookmark › Share
Go
Search posts:

Sarcoma - Articles

New Sarcoma Cancer Treatment Approved in Time for Sarcoma Cancer Awareness Week by WhatNext.com Posted Fri 22 Jun 2012 8:25am   June 18 - 24, 2012 is Sarcoma Cancer Awareness Week. Sarcoma is a rare cancer in adults (1 percent of all adult cancers) but rather prevalent in children (about 15 percent of all childhood cancers). At any one time, 50,000 patients and their families are struggling with sarcoma. Every year, about 12,000 new cases are diagnosed and abo ... Read on »
Votrient for sarcoma by Mark Levin Posted Sat 07 May 2011 12:00am Pazopanib, brand name Votrient,  is an oral angiogenesis inhibitor targeting vascular endothelial growth factor receptor (VEGFR), platelet derived growth factor receptor (PDGFR), and KIT. Inhibitors of VEGFR like pazopanib (Votrient, GlaxoSmithKline), show activity against leiomyosarcoma, synovial sarcoma and other sarcomas including t ... Read on »
Early PET Response To Neoadjuvant Chemotherapy In Sarcoma Patients Predicts Survival Study Finds by Medical Quack Patient ExpertHealth Maven Posted Tue 03 Apr 2012 3:33pm This study appears to say that having a PET scan after the first treatment for chemotherapy gives some indications of how medications are working or not working based on the scan.  If not working it looks like changes can be made early on with examining the condition of the tumor.  BD  Press Release: An early Positron Emission Tom ... Read on »
Merck’s bone sarcoma maintenance drug gets thumbs down from FDAFrom MedCityNews by Francine H. Patient ExpertHealth Maven Posted Tue 05 Jun 2012 12:00am The U.S. Food and Drug Adminsitration has turned down, for now, Merck’s (NYSE: MRK) maintenance drug for metastatic bone sarcoma or metastatic soft tissue sarcoma just a few months after an FDA committee voted overwhelmingly against recommending the drug for approval. The drug is made for adults and pediatric patients, 13 to 17 years old. ... Read on »
High-impact science: Kaposi sarcoma and AIDS – unravelling a medical mystery by Cancer Research UK Patient Expert Posted Fri 22 Jan 2010 12:00am Kaposi's sarcoma is a cancer that causes patches of abnormal tissue to grow Cancer and AIDS – two of the most powerful and emotive words in the English language, and two diseases that touch the lives of millions of people across the world.  Many researchers dedicate their lives to studying them. Cancer Research UK is working ... Read on »
Sarcoma Rears its Ugly Head... by Moshura's Sister Patient Expert Posted Thu 09 Apr 2009 7:13pm Well, Thursday was the day and the results were positive for Sarcoma spreading to the lung. It had grown from 5cm to to 13cm. Now, Marco is at the mercy of the combined chemo drugs known as MAID ( mesna, adriamycin, ifosfomide and dacarbazine. Below are some links that might be useful to understand this combined chemotherapy. Below is s ... Read on »
Temodar for sarcoma by Mark Levin Posted Wed 24 Jun 2009 7:01pm Temodar has some activity in sarcomas as a singel agent. However, while not particularly effective, it is thought to have a place in palliation of resistant disease. Several phase II trials have been performed. Temozolomide is a radiosensitizer that is well tolerated and has modest side effects. It has been studies with radiation in the end ... Read on »
Treatment Update on Soft Tissue Sarcoma by Moshura's Sister Patient Expert Posted Fri 01 Oct 2010 12:00am CancerCare has great presentations you can listen to and share with friends and family. You can listen to one of their recently recorded presentations here Treatment Update on Soft Tissue Sarcoma Topics covered• Overview of soft tissue sarcoma • Current standard of care • New treatment approaches • How clinical trials contribute to t ... Read on »
23andMe Builds Online Sarcoma Research Community by Bruce Friedman Patient Expert Posted Thu 27 Jan 2011 12:00am Here's an interesting development. 23andMe , the online, consumer-oriented genomic testing site, is developing a sarcoma research community (see: 23andMe Achieves Milestone in Building Sarcoma Research Community ). This strikes me a very novel idea that may serve as a forerunner to similar online projects. Below is an excerpt from t ... Read on »
Sutent for non-GIST sarcoma by Mark Levin Posted Mon 11 Apr 2011 12:00am Suten(sunitinib)t is indicated for the treatment of gastrointestinal stromal tumor (GIST), a type of sarcoma, after disease progression on or intolerance to imatinib mesylate. Sutent is also indicated for the treatment of advanced renal cell carcinoma (RCC).   A Phase II clinical trial for sunitinib (S. George et al) in treat ... Read on »